BDBM620522 4-[(3R,4R)-3,4-bis[[1-hydroxy-4-(trifluoromethyl)-3H-2,1-benzoxaborole-6-carbonyl]amino]pyrrolidin-1-yl]-4-oxobutanoic acid::US11767332, Example 29

SMILES OB1OCc2c1cc(cc2C(F)(F)F)C(=O)N[C@@H]1CN(C[C@H]1NC(=O)c1cc2B(O)OCc2c(c1)C(F)(F)F)C(=O)CCC(O)=O

InChI Key InChIKey=AGGOZXDCVADXOG-UHFFFAOYSA-N

Data  2 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 620522   

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620522(4-[(3R,4R)-3,4-bis[[1-hydroxy-4-(trifluoromethyl)-...)
Affinity DataKd:  2.30E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620522(4-[(3R,4R)-3,4-bis[[1-hydroxy-4-(trifluoromethyl)-...)
Affinity DataKd:  2.30E+8nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent